Dermatology · New Orleans, LA
NPI
1790797454
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1430 Tulane Ave, Tb36
New Orleans, LA, 70112
Phone (504) 988-5114
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
1,226 services
Medicare patients, 2024
260
Average age 74
Drug cost, 2024
$7.6M
3,480 prescriptions
Company payments, 2025
$27K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin E Boh was code 17003 (destruction skin lesion), 234 times for 32 patients. In total Erin E Boh billed 1,226 services in 27 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 234 | 32 | $4.17 | $975 |
| 99215 Office E&M - Established | Facility | 152 | 63 | $96.68 | $15K |
| 17003 Destruction Skin Lesion | Facility | 113 | 20 | $1.27 | $143 |
| 99215 Office E&M - Established | Office | 87 | 39 | $115.91 | $10K |
| 17000 Destruction Skin Lesion | Office | 73 | 37 | $41.52 | $3,031 |
| 99213 Office E&M - Established | Office | 59 | 37 | $53.63 | $3,164 |
| 99213 Office E&M - Established | Facility | 52 | 42 | $45.57 | $2,369 |
| 99214 Office E&M - Established | Facility | 46 | 37 | $64.46 | $2,965 |
| 99214 Office E&M - Established | Office | 43 | 27 | $85.88 | $3,693 |
| 17000 Destruction Skin Lesion | Facility | 40 | 29 | $34.65 | $1,386 |
| 99212 Office E&M - Established | Office | 39 | 34 | $38.14 | $1,487 |
| 99212 Office E&M - Established | Facility | 31 | 25 | $21.55 | $668 |
| 17110 Destruction Skin Lesion | Facility | 17 | 15 | $45.88 | $780 |
| 11104 Skin Biopsy | Office | 15 | 14 | $76.15 | $1,142 |
| 99205 Office E&M - New | Facility | 11 | 11 | $138.99 | $1,529 |
By year: 2022 $63K for 1,362 services; 2023 $58K for 1,277 services; 2024 $55K for 1,226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erin E Boh prescribed most often to Medicare patients was Levothyroxine Sodium, with 192 prescriptions and refills. In total Erin E Boh wrote 3,480 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 192 | 308 | 33 | $1,222 |
| Ketoconazole Generic | 186 | 218 | 78 | $2,970 |
| Bexarotene Generic | 179 | 179 | 24 | $1.2M |
| Methotrexate Methotrexate Sodium | 169 | 264 | 46 | $3,122 |
| Triamcinolone Acetonide Generic | 155 | 167 | 86 | $2,312 |
| Hydroxychloroquine Sulfate Generic | 146 | 200 | 34 | $4,004 |
| Prednisone Generic | 140 | 179 | 40 | $701 |
| Fenofibrate Fenofibrate,micronized | 129 | 197 | 27 | $3,017 |
| Otezla Apremilast | 94 | 100 | 13 | $484K |
| Clobetasol Propionate Generic | 83 | 93 | 30 | $4,198 |
| Betamethasone Dipropionate Generic | 77 | 82 | 43 | $4,245 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 72 | 76 | Under 11 | $963K |
| Levocetirizine Dihydrochloride Generic | 71 | 118 | 18 | $528 |
| Dapsone Generic | 67 | 107 | 22 | $6,170 |
| Dupixent Syringe Dupilumab | 66 | 66 | Under 11 | $246K |
Brand drugs: - claims; generic drugs: 2,567 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin E Boh $27K ($27K in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 13 | $21K |
| Genzyme Corporation SNY | 6 | $4,740 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $260 |
| Abbvie Inc. ABBV | 5 | $181 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $148 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $57.68 |
| Amgen Inc. AMGN | 2 | $43.08 |
| Pfizer Inc. PFE | 2 | $36.54 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.53 |
| Genentech USA, Inc. ROG.SW | 1 | $17.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.